CYH

Community Health Systems, Inc.

30
Fundamentals39/ 100
Valuation10/ 100
Upside potential12/ 100
Risk potential86/ 100

CYH's fundamentals are weak and it looks expensive: trading at 8.2x earnings, about four times its usual 2.1x. Its downside scenario is about eight times its upside.

CYH Fundamentals

MetricStatus
Under pressure
Stable
Under pressure
Weak

CYH's profitability is currently stable, but its revenue, cash flow and balance sheet are under pressure.

CYH PE Valuation

CHEAPFAIREXPENSIVE5.9x12x18x24x
CHEAPFAIREXPENSIVE5.9x12x18x24x
LevelPEPriceVs current
Cheap1.3x$0.35-84%
Fair2x$0.55-75%
Expensive4.4x$1.18-47%
Current8.2x$2.21—

Historical ranges are pointers, not guarantees.

CYH's PE is in its expensive range at 8.2x.

CYH Forward outlook

MetricOutlook
--
Losses growing
Decline
Stable
Limited
Low

Analysts expect CYH's losses to grow, with revenue declining. However, they disagree widely on these estimates.

CYH Risk to reward

ScenarioChangePrice
Upside+11%$2.46
Downside-86%$0.31

Calculated from the latest close: $2.21 on Nov 12.

CYH's one-year downside scenario is about eight times its upside: −86% against +11%.

CYH Earnings Per Share

Q4 2023: $-1.02Q1 2024: $-0.94Q2 2024: $-0.75Q3 2024: $-3.01Q4 2024: $-3.90Q1 2025: $-3.68Q2 2025: $-1.49Q3 2025: $2.42Q4 2025: $3.77Q1 2026: $3.44Q2 2026: $1.86Q3 2026: $0.27
Q4 2023: $-1.02Q1 2024: $-0.94Q2 2024: $-0.75Q3 2024: $-3.01Q4 2024: $-3.90Q1 2025: $-3.68Q2 2025: $-1.49Q3 2025: $2.42Q4 2025: $3.77Q1 2026: $3.44Q2 2026: $1.86Q3 2026: $0.27
QuarterTTM EPSYoY
Q3 2026$0.27-89%
Q2 2026$1.86+$3.35
Q1 2026$3.44+$7.12
Q4 2025$3.77+$7.67
Q3 2025$2.42+$5.43
Q2 2025-$1.49-$0.74
Q1 2025-$3.68-$2.74
Q4 2024-$3.90-$2.88

CYH's earnings per share have fallen from their peak: $0.27 over the past year, against $4.39 in late 2020.

CYH Quarterly Revenue

Q4 2023: $3.2BQ1 2024: $3.1BQ2 2024: $3.1BQ3 2024: $3.1BQ4 2024: $3.3BQ1 2025: $3.2BQ2 2025: $3.1BQ3 2025: $3.1BQ4 2025: $3.1BQ1 2026: $3BQ2 2026: $2.8BQ3 2026: $2.8B
Q4 2023: $3.2BQ1 2024: $3.1BQ2 2024: $3.1BQ3 2024: $3.1BQ4 2024: $3.3BQ1 2025: $3.2BQ2 2025: $3.1BQ3 2025: $3.1BQ4 2025: $3.1BQ1 2026: $3BQ2 2026: $2.8BQ3 2026: $2.8B
QuarterRevenueYoY
Q3 2026$2.8B-11%
Q2 2026$2.8B-9.8%
Q1 2026$3B-6.1%
Q4 2025$3.1B-4.9%
Q3 2025$3.1B-0.1%
Q2 2025$3.1B-0.2%
Q1 2025$3.2B+0.6%
Q4 2024$3.3B+2.6%

CYH's revenue has slid since its 2019 peak: $2.8B last quarter, down 11% from the same quarter a year ago.

CYH Free Cash Flow

Q4 2023: −$20MQ1 2024: $3MQ2 2024: $13MQ3 2024: −$3MQ4 2024: $107MQ1 2025: $35MQ2 2025: −$3MQ3 2025: $4MQ4 2025: $172MQ1 2026: −$373MQ2 2026: $12MQ3 2026: $67M
Q4 2023: −$20MQ1 2024: $3MQ2 2024: $13MQ3 2024: −$3MQ4 2024: $107MQ1 2025: $35MQ2 2025: −$3MQ3 2025: $4MQ4 2025: $172MQ1 2026: −$373MQ2 2026: $12MQ3 2026: $67M
QuarterFree cash flowYoY
Q3 2026$67M+1575%
Q2 2026$12M+$15M
Q1 2026-$373M-1166%
Q4 2025$172M+61%
Q3 2025$4M+$7M
Q2 2025-$3M-123%
Q1 2025$35M+1067%
Q4 2024$107M+$127M

CYH's free cash flow was −$122M over the past year, against $143M the year before.

CYH Total Shares

Q4 2023: 130MQ1 2024: 131MQ2 2024: 132MQ3 2024: 132MQ4 2024: 132MQ1 2025: 133MQ2 2025: 135MQ3 2025: 135MQ4 2025: 135MQ1 2026: 134MQ2 2026: 137MQ3 2026: 136M
Q4 2023: 130MQ1 2024: 131MQ2 2024: 132MQ3 2024: 132MQ4 2024: 132MQ1 2025: 133MQ2 2025: 135MQ3 2025: 135MQ4 2025: 135MQ1 2026: 134MQ2 2026: 137MQ3 2026: 136M
PeriodChange %Net change
Quarterly-0.7%-963K shares
1 year+0.3%+355K shares
3 years+3.7%+4.8M shares
5 years+3.6%+4.7M shares
Available history+19%+21.6M shares

CYH has 136M diluted shares, about the same as a year ago.

CYH Net Leverage

Q4 2023: 7.8xQ1 2024: 7.9xQ2 2024: 7.9xQ3 2024: 10.7xQ4 2024: 11.1xQ1 2025: 10.2xQ2 2025: 7.9xQ3 2025: 5.9xQ4 2025: 5.3xQ1 2026: 4.9xQ2 2026: 5.2xQ3 2026: 5.5x
Q4 2023: 7.8xQ1 2024: 7.9xQ2 2024: 7.9xQ3 2024: 10.7xQ4 2024: 11.1xQ1 2025: 10.2xQ2 2025: 7.9xQ3 2025: 5.9xQ4 2025: 5.3xQ1 2026: 4.9xQ2 2026: 5.2xQ3 2026: 5.5x
QuarterNet LeverageStatus
Q3 20265.5xHigh
Q2 20265.2xHigh
Q1 20264.9xHigh
Q4 20255.3xHigh
Q3 20255.9xHigh
Q2 20257.9xHigh
Q1 202510.2xHigh
Q4 202411.1xHigh

CYH's net debt is about 5.5 years of its operating earnings (EBITDA), down from 5.9 years a year ago.

CYH Weekly Momentum

MetricValueStatus
RSI34.4Neutral
Stochastic19.0Oversold

CYH's weekly RSI is 34 (neutral) and its Stochastic is 19 (oversold).

CYH PE vs Healthcare Sector

MetricCYHSector medianRelative
PE8.2x26x68% below
PE %922963 pts above

CYH is trading at 8.2x earnings, a 68% discount to the Healthcare sector's median of 26x.

CYH Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$2.6316% below
20 week MA$2.9024% below
50 week MA$3.0327% below
100 week MA$3.0928% below
200 week MA$3.5538% below

CYH is in a downtrend: it's below all five of its weekly moving averages, and 38% below its 200-week average.

CYH Yearly ROI

YearStart priceEnd priceROI
2020$2.77$7.67+177%
2021$7.67$13.3+73%
2022$13.3$3.88-71%
2023$3.88$3.13-19%
2024$3.13$3.03-3.2%
2025$3.03$3.23+6.6%
2026 YTD$3.23$2.21-32%

CYH's yearly returns have swung widely, from +177% in 2020 to −71% in 2022. It's down 32% so far in 2026.

Give your agent the market.

Get API key